Clinical Trials Logo

Morbidity clinical trials

View clinical trials related to Morbidity.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04445428 Active, not recruiting - COVID Clinical Trials

OPV as Potential Protection Against COVID-19

Start date: July 15, 2020
Phase: Phase 4
Study type: Interventional
Read more »
NCT ID: NCT03480399 Active, not recruiting - Quality of Life Clinical Trials

Long Term Morbidity and Quality of Life in Retroperitoneal Sarcomas

LTM
Start date: January 2014
Phase:
Study type: Observational
Read more »
NCT ID: NCT03460002 Active, not recruiting - Children Clinical Trials

Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children

RE-CAMP
Start date: November 2016
Phase: Phase 4
Study type: Interventional
Read more »
NCT ID: NCT01396993 Active, not recruiting - Quality of Life Clinical Trials

Prospective Non-randomized Evaluation of Oncoplastic Surgery

iTOP
Start date: July 2011
Phase: N/A
Study type: Observational

Breast conserving therapy (BCT) is the standard treatment for intraductal or invasive breast cancer patients. However cosmetic results, e.g. symmetry and nipple displacement, are sometimes poor reducing the quality of life. The use of immediate techniques for oncoplastic surgery (iTOP) seems to improve subjective cosmetic outcome. Oncologic safety of iTOP has been demonstrated by several authors using restrospective analyses. However, no prospective observational trial has been done to objectively evaluate cosmetic and oncologic outcome comparing BCT with iTOP. The aim of this study is to investigate this issue within a prospective non randomized observational trial at the Medical University Vienna.

NCT ID: NCT00168623 Active, not recruiting - Mortality Clinical Trials

Vitamin A Supplementation With Routine Childhood Vaccines and Mortality and Morbidity

Start date: November 2003
Phase: Phase 4
Study type: Interventional

Vitamin A supplementation (VAS) is important for the immune system and may interact with different childhood vaccinations. We have hypothesized that the improved survival after VAS may depend on vitamin A amplifying the non-specific immune modulation induced by vaccinations. In the present study we used information collected in connection with a national vitamin A campaign in Guinea-Bissau during which different doses of VAS was provided together with missing doses of DTP, OPV, and measles vaccines. We aimed to study the potential interactions between VAS and vaccine type.

NCT ID: NCT00168610 Active, not recruiting - Morbidity Clinical Trials

Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine

Start date: November 2004
Phase: Phase 4
Study type: Interventional

In the present study the investigators wish to address the effects of different doses of vitamin A supplementation in low and normal birth weight infants. Hypotheses: - Vitamin A supplementation administered at birth together with BCG vaccination is associated with a 30% reduction in infant mortality and morbidity during the first year of life in both normal and low birth weight infants. - A lower dose of vitamin A may be even more beneficial than a high dose.